1 To study the mechanisms of vascular injury and repair in type 2 diabetic nephropathy, and form a new body of knowledge
2 To study biomarkers that can detect early vascular, and renal microvascular disease
3 To minimize the number of chronic kidney disease patients associated with type 2 diabetes, and prevent them from entering ESRD, by using a new therapeutic approach aiming at restoration of renal function.